NUTRA PHARMA CORP
- CIK: 0001119643
- EIN: 91-2021600
- Business address: 12538 W. ATLANTIC BLVD., CORAL SPRINGS, Florida, 33071
Information
Mailing address
12538 W. ATLANTIC BLVD., CORAL SPRINGS, California, 33071Phone
(954) 509-0911State location
FloridaState of incorporation
CaliforniaFiscal year end
December 31SIC
2833 - (CF Office: Office of Life Sciences) MEDICINAL CHEMICALS & BOTANICAL PRODUCTSFilings
N/A
About NUTRA PHARMA CORP
NUTRA PHARMA CORP (CIK: 0001119643) is an American company incorporated in the state of Florida. Head office is located at 12538 W. ATLANTIC BLVD., CORAL SPRINGS, Florida, 33071. Work in the industry 2833 - (CF Office: Office of Life Sciences) MEDICINAL CHEMICALS & BOTANICAL PRODUCTS. NUTRA PHARMA CORP is a public company and trade via Over-The-Counter (OTC).Old names:
- CYBER VITAMIN COM from 2000-03-Oct to 2002-28-Feb
Ownership
| Owner | Filings | Transaction Date | Type of Owner |
|---|---|---|---|
| ORAN DAN | 0001705481 | Jun-17-2016 | director |
| SARTORI BRUNO | 0001108410 | Feb-10-2012 | other: Former CFO |
| Rumph Harold Henry | 0001476235 | Feb-10-2012 | director, officer: President - ReceptoPharm |
| ISSERMAN DAVID MICHAEL | 0001483799 | Feb-11-2010 | officer: Chief Marketing Officer |
| POTTRUCK GARRY | 0001480951 | Jul-29-2009 | director |
| REID PAUL F | 0001481668 | Apr-14-2008 | director |
| DOHERTY MICHAEL | 0001251265 | Jun-01-2005 | director, officer: Executive Chairman |
| Khandaker Tanvir A | 0001322964 | Jan-26-2005 | director |
| Lonky Stewart Alan | 0001323546 | Jan-26-2005 | director |
| CHERELSTEIN STANLEY JACK | 0001322956 | Nov-05-2004 | director |
| FLAX MICHAEL | 0001168729 | Nov-30-2003 | director, officer: Chief Financial Officer |
| MCCLELLAND DAVID C SR | 0001285083 | Nov-17-2003 | director |
| FELDER MITCHELL S | 0001285072 | Oct-30-2003 | director |
| DEITSCH RIK J | 0001266490 | Jun-09-2003 | officer: Chief Executive Officer |
| KHALSA SORAM SINGH MD | 0001168730 | Dec-31-2002 | director |
| ENGELBRECHT ZIRK | 0001169361 | Dec-31-2002 | director, officer: Chief Financial Officer |
Stock Chart
Coming soon!
Jobs
Coming soon!
Recent SEC Filings
Includes all SEC registration details as well as a list of all documents (S-1, Prospectus, Current Reports, 8-K, 10K, Annual Reports) filed by NUTRA PHARMA CORP
| Filings | Format | Description | Filed/Effective | File/Film Number |
|---|---|---|---|---|
| 8-K | Document | Current report filing Acc-no: 0001493152-24-010998 (34 Act) Size: 257 KB |
Mar-22-2024 | 24775829 |
| 10-Q | Document | Quarterly report pursuant to sections 13 or 15(d) Acc-no: 0001493152-22-033171 (34 Act) Size: 9288 KB |
Nov-21-2022 | 221406817 |
| NT 10-Q | Document | Notice under Rule 12b25 of inability to timely file all or part of a form 10-Q or 10-QSB Acc-no: 0001493152-22-032495 (34 Act) Size: 26 KB |
Nov-15-2022 | 221391185 |
| 10-Q | Document | Quarterly report pursuant to sections 13 or 15(d) Acc-no: 0001493152-22-023751 (34 Act) Size: 9074 KB |
Aug-22-2022 | 221184372 |
| NT 10-Q | Document | Notice under Rule 12b25 of inability to timely file all or part of a form 10-Q or 10-QSB Acc-no: 0001493152-22-022953 (34 Act) Size: 26 KB |
Aug-15-2022 | 221166542 |
| 8-K | Document | Current report filing Acc-no: 0001493152-22-021351 (34 Act) Size: 411 KB |
Aug-04-2022 | 221137342 |
| 10-Q | Document | Quarterly report pursuant to sections 13 or 15(d) Acc-no: 0001493152-22-014637 (34 Act) Size: 8236 KB |
May-20-2022 | 22948445 |
| NT 10-Q | Document | Notice under Rule 12b25 of inability to timely file all or part of a form 10-Q or 10-QSB Acc-no: 0001493152-22-013761 (34 Act) Size: 26 KB |
May-16-2022 | 22928782 |
| 10-K | Document | Annual report pursuant to section 13 and 15(d) Acc-no: 0001493152-22-010035 (34 Act) Size: 9926 KB |
Apr-15-2022 | 22829456 |
| NT 10-K | Document | Notice under Rule 12b25 of inability to timely file all or part of a Form 10-K, 10-KSB, or 10KT Acc-no: 0001493152-22-008863 (34 Act) Size: 25 KB |
Apr-01-2022 | 22799113 |
| DEF 14C | Document | Definitive information statements Acc-no: 0001493152-22-007568 (34 Act) Size: 176 KB |
Mar-24-2022 | 22764112 |
| 5 | Document | Annual statement of changes in beneficial ownership of securities Acc-no: 0001493152-22-001313 ( Act) Size: 7 KB |
Jan-14-2022 | |
| SC 13D/A | Document | Amendment to Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities Acc-no: 0001493152-22-001307 (34 Act) Size: 61 KB |
Jan-14-2022 | 22532664 |
| PRE 14C | Document | Preliminary information statement not related to a contested matter or merger/acquisition Acc-no: 0001493152-22-001304 (34 Act) Size: 175 KB |
Jan-14-2022 | 22532643 |
| 10-Q | Document | Quarterly report pursuant to sections 13 or 15(d) Acc-no: 0001493152-21-027793 (34 Act) Size: 9652 KB |
Nov-10-2021 | 211395520 |
| 10-Q | Document | Quarterly report pursuant to sections 13 or 15(d) Acc-no: 0001493152-21-023540 (34 Act) Size: 10075 KB |
Sep-24-2021 | 211275537 |
| 10-Q | Document | Quarterly report pursuant to sections 13 or 15(d) Acc-no: 0001493152-21-022993 (34 Act) Size: 6509 KB |
Sep-17-2021 | 211260226 |
| 10-K | Document | Annual report pursuant to section 13 and 15(d) Acc-no: 0001493152-21-022204 (34 Act) Size: 8457 KB |
Sep-08-2021 | 211242212 |
| 10-Q | Document | Quarterly report pursuant to sections 13 or 15(d) Acc-no: 0001493152-21-019469 (34 Act) Size: 8071 KB |
Aug-12-2021 | 211167000 |
| 10-Q | Document | Quarterly report pursuant to sections 13 or 15(d) Acc-no: 0001493152-21-018715 (34 Act) Size: 8088 KB |
Aug-05-2021 | 211147945 |
Recent 20 filings. View all NUTRA PHARMA CORP filings
Reviews
Jean Bishop
Very good communication and delivery made within the timeframe I was advised of
Catherine
Thanks I look forward to using the product to improve my skin tone
Pelisari
young lad who new his job ansered questions and new what was best for me.
Frequently Asked Questions
Tags:
- NUTRA PHARMA CORP overview
- NUTRA PHARMA CORP job
- NUTRA PHARMA CORP stock
- NUTRA PHARMA CORP ownership
- NUTRA PHARMA CORP CEO
- NUTRA PHARMA CORP documents
Disclaimer: The information on the Service is provided with the understanding that the Company is not herein engaged in rendering legal, accounting, tax, or other professional advice and services. As such, it should not be used as a substitute for consultation with professional accounting, tax, legal or other competent advisers.
Orther Companies
Cordyceps Sunshine Biotech Holdings Co., Ltd.
Update: Jan 21, 2023
PSLY.COM, Inc.
Update: Aug 29, 2022
Jushi Holdings Inc.
Update: Aug 29, 2022
ZACHARY VENTURES INC
Update: Aug 25, 2022
WEIKANG BIO-TECHNOLOGY GROUP CO., INC.
Update: Aug 25, 2022
VITAQUEST INTERNATIONAL INC
Update: Aug 24, 2022
Latest News
SEC Adopts Rules to Improve Clearing Agency Governance and Mitigate...
Charter Communications to Pay $25 Million Penalty for Unauthorized...
SEC Announces Enforcement Results for Fiscal Year 2023
SEC Charges Former Co-CEOs of Tech Start-Up Bitwise Industries...
SEC Charges Royal Bank of Canada with Internal Accounting Controls...
SEC Charges President/CCO of Prophecy Asset Management Advisory...
SEC Adopts Rules for the Registration and Regulation of Security-Based...
SEC Charges Crypto Company SafeMoon and its Executive Team for...
© 2022 